Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959620 · ClinicalTrials.gov registry record · NA
Optimal Dose of Early Intervention to Prevent PTSD
A NA study of Post Traumatic Stress Disorder, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 1
- Study location
NCT01959620: Completed NA study of Post Traumatic Stress Disorder, sponsored by Emory University.
NCT01959620 is a NA study of Post Traumatic Stress Disorder that has completed, run by Emory University. The registered enrollment target is 95 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01959620, a NA study of Post Traumatic Stress Disorder, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this study is to determine the optimal dose, 3-session exposure intervention versus 1-session exposure intervention compared to no treatment, for the delivery of exposure therapy in the immediate aftermath of trauma for preventing the development of posttraumatic stress disorder.
Conditions Studied
Interventions
- BEHAVIORAL 1-Session Exposure Therapy
- BEHAVIORAL 3-Session Exposure Therapy
Study Locations (1)
Georgia
- Grady Memorial Hospital, Emergency Department - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT01959620 record still lists
NCT01959620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which 1-Session Exposure Therapy is the first listed.
NCT01959620 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01959620 about?
NCT01959620 is a clinical study titled "Optimal Dose of Early Intervention to Prevent PTSD". The overall aim of this study is to determine the optimal dose, 3-session exposure intervention versus 1-session exposure intervention compared to no treatment, for the delivery of exposure therapy in the immediate aftermath of trauma for preventing the development of posttraumatic stress disorder.
What is the current status of trial NCT01959620?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2013-10. Estimated completion is 2016-12.
What conditions does trial NCT01959620 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT01959620?
The interventions under investigation include: 1-Session Exposure Therapy (BEHAVIORAL), 3-Session Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01959620?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01959620 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01959620's enrollment target sits among peer trials
95 118th of 262 higher than 144 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia